Abstract
Purpose
The aim of this study is to evaluate and compare sexual satisfaction with the use of three types of hormonal contraceptives.
Methods
We have evaluated the sexological profile of 23 patients, treated with a subdermal hormonal contraceptive containing 68 mg etonogestrel. We have compared this profile to that of other two groups of previously studied patients: one consisting of 26 women treated with a vaginal ring releasing 120 µg/day of etonogestrel and 15 µg/day of ethinylestradiol (EE) and one consisting of 25 women treated with an oral contraceptive containing 20 µg of EE and 150 µg of desogestrel. A further group of 25 women, not in treatment with any type of hormonal contraceptive, has been studied as control group. The Interviewer Rating of Sexual Function (IRSF) has been completed by the patients at the beginning of the study and after cycles of 3 and 6 months of contraceptive usage.
Results
All three types of hormonal contraceptives have increased positive indicators of patients’ sexual life (sexual interest and fantasies, of orgasm number and intensity and satisfaction) and decreased negative ones (anxiousness, discomfort).
Conclusions
Subdermal contraception is slower than both intravaginal and oral hormonal contraceptives in giving these effects, but is more effective after a cycle of 6 months of usage.
Similar content being viewed by others
References
Piccinino LJ, Mosher WD (1998) Trends in contraceptive use in the United States: 1982–1995. Fam Plann Perspect 30:4–10
Rosenberg MJ, Meyers A, Roy V (2000) Efficacy, cycle control and side effects of low and lower dose oral contraceptives: a randomized trial of 20 and 35 µg estrogen preparations. Contraception 60:321–329
Bjarnadottir RI, Tuppurainem M, Killik SR (2002) Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinylestradiol. Am J Obstet Gynecol 186:389–395
Sabatini R (2004) NuvaRing and sexual comfort. Giorn Ital Ostet Ginecol 26:321–324
Bitzer J, Simon JA (2011) Current issues and available options in combined hormonal contraception. Contraception 84:342–356
Sanders SA, Graham CA, Bass JL, Bancroft J (2001) A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 64:51–58
Caruso S, Agnello C, Intelisano G, Farina M, DiMari L, Cianci A (2004) Sexual behavior of women taking low-dose oral contraceptive containing 15 µg ethinylestradiol/60 µg gestodene. Contraception 69:234–237
Schnabel P, Mommers E, Marintcheva-Petrova M (2009) Bioequivalence and X-ray visibility of radiopaque etonogestrel implant and Implanon. Abstract presented at the 8th Congress of the European Society of Gynecology, Rome, pp 10–13
Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt HJ et al (2010) Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 82:243–249
Walling MR (2010) Nexplanon the next step to the contraceptive implant. Woman’s Health J Prim Care 2(3):113–114
Mommers E, BlumGF Gent TG, Peters KP, Sørdal TS, Marintcheva-Petrova M (2012) Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. Am J Obstet Gynecol 207(5):388.e1–388.e6
Wynn V, Adams PW, Folkard J, Secd M (1975) Tryptophan, depression and steroidal contraception. J Steroid Biochem 6:965–970
Trussell J, Westoff CF (1980) Contraceptive practice and trends in coital frequency. Fam Plann Prospect 12:246–249
Oddens BJ (1999) Women’s satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 59:277–286
Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TMM (1995) The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progesterone-only methods. Contraception 52:363–369
Caruso S, Iraci Sareri M, Agnello C, Romano M, Lo Presti L, Malandrino C, Cianci A (2011) Conventional versus estende-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol. J Sex Med 8:1478–1485
Guida M, Di SpiezioSardo A, Bramante S, Sparice S, Acunzo G, Tommaselli GA, Di Carlo C, Pellicano M, Greco E, Nappi C (2005) Effects of two types of hormonal contraception -oral versus intravaginal- on the sexual life of women and their partners. Hum Reprod 20(4):1100–1106
Bancroft J, Tyrer G, Warnwr P (1982) The assessment of sexual problems in women. Br J Sex Med 9:30–37
Tyrer G, Steel JM, Ewing DJ, Bancroft J, Warner P, Clark BF (1983) Sexual responsiveness in diabetic women. Diabetologia 24:166–171
Gibbs N (2011) Love, sex, freedom and the paradox of the pill: a brief history of birth control, Kindle Edition. Time Inc., New York
Williams Sanithia L, Parisi Sara M, Rachel Hess E, Schwarz Bimla (2012) Associations between recent contraceptive use and quality of life among women. Contraception 85(3):282–287
Burrows Lara J, Basha Maureen, Goldstein Andrew T (2012) The Effects of Hormonal Contraceptives on Female Sexuality: A Review. J sex Med 9–9:2213–2223
Bancroft J (1988) Sexual desire and the brain. Sex Marital Ther 3:11–27
Basson R, Berman J, Burnet A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E et al (2000) Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 163:888–893
Walton B, Trashawn T (2003) Femal sexual dysfunction. Curr Women’s Health Report 3:319–326
Guida M, Visconti F, Cibarelli F, Granozio G, Troisi J, Martini E, Nappi R (2014) Counseling and management of patients requesting subcutaneous contraceptive implants: proposal for a decisional algorithm. Gynecol Endoc. doi:10.3109/09513590.2014.899348
Masters and Johnson (1987) On sex and human loving. Little, Brown
Egarter C, Topcuoglu MA, Imhof M, Huber J (1999) Low dose oral contraceptives and quality of life. Contraception 59:287–291
Battaglia C, Battaglia B, Mancini F, Busacchi P, Paganotto MC, Morotti E, Venturoli S (2012) Sexual behavior and oral contraception: a pilot study. J Sex Med 9:550–557
Coenen CMH, Thomas CMG, Borm GF, Hollanders JMG, Rollando R (1996) Changes in androgens during treatment with four low-dose contraceptives. Contraception 53:171–176
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
All authors have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Guida, M., Cibarelli, F., Troisi, J. et al. Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration. Arch Gynecol Obstet 290, 1239–1247 (2014). https://doi.org/10.1007/s00404-014-3323-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-014-3323-4